Structure-affinity studies of C-terminally modified analogs of neuropeptide Y led to a novel class of peptidic Y1 receptor antagonist

Regulatory Peptides

Volumn 65, Issue 1, 1996, Pages 61-70

  Hoffmann, Susanne ^a   Rist, Beate ^b   Videnov, Georgi ^a   Jung, Günther ^a   Beck Sickinger, Annette G ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR ANTAGONIST;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

EID: 0030603862     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-0115(96)00073-0     Document Type: Article

References (35)

1. [1] Glover, I., Barlow, D.J., Pitts, J., Wood, S.D., Tickle, I., Blundell, T.L., Tatemoto, K., Kimmel, J.R., Wollmer, A., Strassburger, W. and Zhang, Y.-S., Conformational studies on the pancreatic polypeptide hormone family, Eur. J. Biochem., 142 (1995) 379-385.
2. [2] Allen, J., Novotny, J., Martin, J. and Heinrich, G., Molecular structure of mammalian neuropeptide Y: analysis by molecular cloning and computer-aided comparison with crystal structure of avian homologue, Proc. Natl. Acad. Sci. USA, 84 (1987) 2532-2536.
3. [3] Tatemoto, K., Carlquist, M. and Mutt, V. Neuropeptide Y - A novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide, Nature (Lond.), 296 (1982) 659-660.
4. [4] Tatemoto, K., Complete amino acid sequence of the brain peptide, Proc. Natl. Acad. Sci. USA. 79, (1982) 5485-5489.
5. [5] Zukowska-Grojec, Z. and Wahlestedt C., Origin and actions of neuropeptide Y in the cardiovascular system. In W.F. Colmers and C. Wahlestedt (Eds.). The Biology of Neuropeptide Y and Related Peptides, Humana Press, Totowa, NJ, 1993, pp. 315-388.
6. [6] Grundemar, L., Sheikh, S.P. and Wahlestedt C., Characterization of receptor types for neuropeptide Y and related peptides. In W.F. Colmers and C. Wahlestedt (Eds.), The Biology of Neuropeptide Y and Related Peptides, Humana Press, Totowa, NJ, 1993, pp. 197-239.
7. [7] Wahlestedt, C. and Reis, D.J., Neuropeptide Y-related peptides and their receptors - Are the receptors potential therapeutic drug targets? Annu. Rev. Pharmacol. Toxicol., 32 (1993) 309-318.
8. [8] Colmers, W.F. and Bleakman, D., Effects of neuropeptide Y on the electrical properties of neurons (review). Trends Neurosci., 17 (1994) 373-379.
9. [9] Wahlestedt, C., Yanaihara, N. and Håkanson, R., Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides, Regul. Pept., 13 (1986) 307-318.
10. 1 receptor agonist, Proc. Natl. Acad. Sci. USA, 87 (1990) 182-186.
11. [11] Eva, C., Kemanen, K., Monyer, H., Seeburg, P. and Sprengel, R., Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family, FEBS Lett., 271 (1990) 80-84.
12. 1 subtype pharmacology of a recombinantly expressed neuropeptide receptor, Mol. Pharmacol., 41 (1992) 817-821.
13. [13] Herzog, H., Hort, Y., Ball, H.J., Hayes, G., Shine, J. and Selbie, L.A., Cloned human neuropeptide Y receptor couples to two different second messenger systems, Proc. Natl. Acad. Sci. USA, 89 (1992) 5794-5798.
14. 1 type, J. Biol. Chem., 267 (1992) 10935-10938.
15. [15] Michel, M.C., Receptors for neuropeptide Y: multiple subtypes and multiple second messengers, Trends Pharmacol. Sci., 12 (1991) 392-394.
16. [16] Giannis, A. and Kolter, T., Peptidmimetika für Rezeptorliganden -Entdeckung, Entwicklung und medizinische Aspekte, Angew. Chem., 105 (1993) 1303-1326.
17. 2-receptors (review), Biopolymers (Peptide Science), 37 (1995) 123-142.
18. 2 receptors with distinghuished conformations, Eur. J. Biochem., 225 (1994) 947-958.
19. [19] Beck-Sickinger, A.G., Dürr. H., Hoffmann, E., Gaida, W. and Jung, G., Characterisation of the binidng site of neuropeptide Y to the rabbit kidney receptor using multiple peptide synthesis. Biochem. Soc. Trans., 20, (1993) 847-850.
20. 2 receptor, Eur. J. Biochem., 206 (1992) 957-964.
21. [21] Martinez, J., Rodriguez, M., Bali, J.-P. and Laur, J., Phenylethylamide derivatives of the C-terminal tetrapeptide of gastrin. Potent inhibitors of gastrin-stimulated acid secretion. Int. J. Pept. Protein Res., 28 (1996) 529-535.
22. [22] Heimbrook, D.C., Saari, W.S., Balishin, N.L., Friedman, A., Moore, K.S., Riemen, M.W., Kiefer, D.M., Rotberg, N.S., Wallen, J.W. and Oliff, A., Carboxy-terminal modification of a gastrin releasing peptide derivative generates potent antagonists, J. Biol. Chem., 264 (1989) 11258-11262.
23. [23] Spanarkel, M., Martinez, J., Briet, C., Jensen, R.T. and Gardner, J.D., Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists, J. Biol. Chem., 258, (1983) 6746-6749.
24. 1 receptor antagonist: BIBP 3226, Eur. J. Pharmacol., 271 (1994) R11-R13.
25. [25] Scheibye, S., Petersen, B.S. and Lawesson, S.O., Studies on organophosphorus compounds XXI. The dimer of p-methoxyphenylthionophosphine sulfide as a thiation reagent. A new route to thiocarboxamides. Bull. Soc. Chim. Belg., 87 (1978) 229-238.
26. [26] Grynkiewicz, G., Poenie, M. and Tsien, R.Y., A new generation of calcium indicators with greatly improved fluorecence properties, J. Biol. Chem., 260 (1985) 3440-3450.
27. 1 neuropeptide Y receptor m ligand binding. Mol. Cell. Endocrinol., 112 (1995) 215-222.
28. [28] Balasubramaniam, A. and Sheriff, S., Neuropeptide Y (18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventricular membranes, J. Biol. Chem., 265 (1990) 14724-14727.
29. [29] Herzog, H., Hort, Y., Shine, J. and Selbie, L.A., Molecular cloning, characterisation and localization of the human homolog to the reported bovine NPY Y3 receptor: lack of NPY binding and activation. DNA Cell. Biol., 12 (1993) 465-471.
30. [30] Tatemoto, K., Mann, M.J. and Shimizu, M., Synthesis of receptor antagonists of neuropeptide Y. Proc. Natl. Acad. Sci. USA, 89 (1992) 1174-1178.
31. 1 type receptor. J. Med. Chem., 38 (1995) 1150-1157.
32. [32] Adamsson, M. and Edvinsson, L., Blockade of neuropeptide Y -induced potentiation of noradrenaline-evoked vasoconstriction by D-myo-inositol 1,2,6-triphosphate (PP56) in rabbit femoral arteries, Neuropeptides, 19 (1991) 13-16.
33. 3H]neuropeptide Y displacement activity, J. Med. Chem., 36 (1993) 272-279.
34. [34] Michel, M.C. and Buschauer, A., Neuropeptide Y and its antagonists, Drugs Future, 17 (1992) 39-45.
35. [35] Serradeil-Le Gal, C., Valette, G., Rouby, P.-E., Pellet, A., Oury-Donat, F., Brossard, G., Lesdy, L., Marty, E., Neliat, G., deCointet, P., Maffrand, J.-P. and Le Fur, G., SR 120819A, an orally-active and selective neuropeptide Y Y1 receptor antagonist, FEBS Lett. 362 (1995) 192-195.